PFE buying ANAC is a good deal. PFE, AMGN, and perhaps GILD can get MDVN for $75 or above. SNY might make a more favorable bid, but MDVN is worth more than $75 based on fair valuation. AMGN might be best to put up the $75.
Not sure anything is "in the bag". Just because a pushy French company claims they have talked to main shareholders means nothing. Forbes did an interview with the fifth largest holder who said he didn't want to sell and thought the shares were worth at least $100.
Pfizer paid 5.2 billion for a particular drug that is in phase two and will have peak sales of 2 billion.... Medivation will eventually have three cancer drugs, one already FDA approved generating 1.6 billion annually, and two that are in phase two and could possibly generate another 2-4 billion annually. Please remind me why the buyout price will be between 65 and 75? I believe this company should be bought out at roughly 14-15 billion. Hopefully with the pile of cash ($21 billion) Gilead has they will come in and pick up the company for 14 billion, which would be $85 a share. Once all three medications are FDA approved, they will have a strong oncology pipeline that's generating 6-8 billion a year..
Sentiment: Strong Buy
Actually it would be a 'shareholder vote' - but of course SNY already talked to the big holders- so board change should be in the bag. (We will be notified when proxy is approved and ready to 'vote').
$99 a share, previous close was $66 a share... That's insane. I sure hope a big pharma company will bet on Medivation and pay high.
and yes, PFE could be betting here too. they got the money and the desire for more oncology... I expect news this week before SNY gets a chance to name their board.
Don't trade on hope or fantasy, trade on the facts and I guarentee you'll make vs. lose money. Sell AMAG and but it all into MDVN as the bidding has just started. Final buyout will be over $70 as MDVN has a great product line/pipeline and there are many of the big pharma companies that want it.
"I still think AZN will take MDVN home."
That could well be Lurker, but I know when my wife goes shopping she gets into the groove and doesn't stop until the money is gone. I have noticed with some of these biotech buyouts the same trend, once the buying starts it seems they get into the buying mood. I would not count Pfizer out.
why are you telling us this? No one cares here. you should be posting this at SNY and AMAG boards.
If Anacor is worth $5 billion what is MDVN worth?
Boggles the mind
Could a buyout offer be coming for AMAG pretty soon ...
Is Pfizer on a buying spree? They had a $160 Billion deal called off so they have "money to burn" and they may do an AbbVie and start a buying spree. Shire bought Dyax earlier this year and is now wrapping up an aquisition of Baxalta, this could be a trend. Good Luck.
PFE - Buying ANAC for $5.2 B 16-MAY.. Maybe they already know that AMGN might make the highest bid for MDVN? MDVN can get at least $75 from a fairly valuable bidder. Might just be AMGN.
I wish I had everything in a Roth, all of my investments are in a Fidelity IRA so taxes will apply as I draw from it.. Good luck with MDVN